These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

166 related items for PubMed ID: 4687219

  • 1. Involvement of nigro-striatal neurons in the in vivo release of dopamine by amphetamine, amantadine and tyramine.
    Von Voigtlander PF, Moore KE.
    J Pharmacol Exp Ther; 1973 Mar; 184(3):542-52. PubMed ID: 4687219
    [No Abstract] [Full Text] [Related]

  • 2. Release of endogenously synthesized catechols from the caudate nucleus by stimulation of the nigro-striatal pathway and by the administration of d-amphetamine.
    Chiueh CC, Moore KE.
    Brain Res; 1973 Feb 14; 50(1):221-5. PubMed ID: 4690549
    [No Abstract] [Full Text] [Related]

  • 3. Dopamine and norepinephrine uptake by rat brain synaptosomes: relative inhibitory potencies of 1- and d-amphetamine and amantadine.
    Thornburg JE, Moore KE.
    Res Commun Chem Pathol Pharmacol; 1973 Jan 14; 5(1):81-9. PubMed ID: 4686111
    [No Abstract] [Full Text] [Related]

  • 4. Lack of effect of amantadine on d-amphetamine-induced release of dopamine from cat brain in vivo.
    Gudelsky GA, McCall RB, Chiueh CC, Moore KE.
    Res Commun Chem Pathol Pharmacol; 1974 Dec 14; 9(4):653-60. PubMed ID: 4456497
    [No Abstract] [Full Text] [Related]

  • 5. Relative potencies of d- and l-amphetamine on the release of dopamine from cat brain in vivo.
    Chiueh CC, Moore KE.
    Res Commun Chem Pathol Pharmacol; 1974 Jan 14; 7(1):189-99. PubMed ID: 4811449
    [No Abstract] [Full Text] [Related]

  • 6. Amphetamine inhibits the electrically evoked release of [3H]dopamine from slices of the rabbit caudate.
    Kamal LA, Arbilla S, Galzin AM, Langer SZ.
    J Pharmacol Exp Ther; 1983 Nov 14; 227(2):446-58. PubMed ID: 6631724
    [Abstract] [Full Text] [Related]

  • 7. Proceedings: The effects of amantadine, tranylcypromine, amphetamine and tyramine on the response of the rat anococcygeus muscle after bretylium.
    Cunnane T, Draper AJ, Redfern PH.
    J Pharm Pharmacol; 1975 Dec 14; 27 Suppl?-2():14P. PubMed ID: 2686
    [No Abstract] [Full Text] [Related]

  • 8. Presynaptic modulation of the release of dopamine from the rabbit caudate nucleus: differences between electrical stimulation, amphetamine and tyramine.
    Kamal LA, Arbilla S, Langer SZ.
    J Pharmacol Exp Ther; 1981 Mar 14; 216(3):592-8. PubMed ID: 6259324
    [No Abstract] [Full Text] [Related]

  • 9. D-amphetamine-induced release of "newly synthesized" and "stored" dopamine from the caudate nucleus in vivo.
    Chiueh CC, Moore KE.
    J Pharmacol Exp Ther; 1975 Mar 14; 192(3):642-53. PubMed ID: 1120962
    [Abstract] [Full Text] [Related]

  • 10. [Behavioral activation developing after cessation of electrical stimulation of the caudate nucleus].
    Shishliannikova LV.
    Fiziol Zh SSSR Im I M Sechenova; 1980 Aug 14; 66(8):1165-70. PubMed ID: 7191378
    [Abstract] [Full Text] [Related]

  • 11. Dopamine: release from the brain in vivo by amantadine.
    Von Voigtlander PF, Moore KE.
    Science; 1971 Oct 22; 174(4007):408-10. PubMed ID: 5111993
    [Abstract] [Full Text] [Related]

  • 12. In vivo spontaneous and evoked release of newly synthesized dopamine in the cat caudate nucleus.
    Besson MJ, Cheramy A, Gauchy C, Glowinski J.
    Adv Neurol; 1974 Oct 22; 5():69-78. PubMed ID: 4155237
    [No Abstract] [Full Text] [Related]

  • 13. The effect of dihydroxyphenylalanine, pheniprazine and dextroamphetamine on the in vivo release of dopamine from the caudate nucleus.
    McKenzie GM, Szerb JC.
    J Pharmacol Exp Ther; 1968 Aug 22; 162(2):302-8. PubMed ID: 4385909
    [No Abstract] [Full Text] [Related]

  • 14. Origin of various enzymes released from the substantia nigra and caudate nucleus: effects of 6-hydroxydopamine lesions of the nigro-striatal pathway.
    Greenfield SA, Grünewald RA, Foley P, Shaw SG.
    J Comp Neurol; 1983 Feb 10; 214(1):87-92. PubMed ID: 6404955
    [Abstract] [Full Text] [Related]

  • 15. [Cellular response to nigro-strial excitation: pharmacological tests by perfusion of the caudate nucleus surface].
    Feltz P.
    J Physiol (Paris); 1970 Feb 10; 62 Suppl 3():374. PubMed ID: 5515973
    [No Abstract] [Full Text] [Related]

  • 16. The effect of dopamine uptake blocking agents on the amphetamine-induced circling behavior in mice with unilateral nigro-striatal lesions.
    Fung YK, Uretsky NJ.
    J Pharmacol Exp Ther; 1980 Sep 10; 214(3):651-6. PubMed ID: 6772760
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Behavioral effects of direct- and indirect-acting dopaminergic agonists.
    Moore KE.
    Adv Biochem Psychopharmacol; 1974 Sep 10; 12(0):403-14. PubMed ID: 4371765
    [No Abstract] [Full Text] [Related]

  • 19. [Stereotypical behavior developing after electric stimulation of the substantia nigra in cats].
    Arushanian EB, Tolpyshev BA, Baturin VA.
    Zh Vyssh Nerv Deiat Im I P Pavlova; 1981 Sep 10; 31(4):711-8. PubMed ID: 7197857
    [Abstract] [Full Text] [Related]

  • 20. Amphetamine attenuates the stimulated release of dopamine in vivo.
    Kuhr WG, Ewing AG, Near JA, Wightman RM.
    J Pharmacol Exp Ther; 1985 Feb 10; 232(2):388-94. PubMed ID: 3968641
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.